サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629904

医療用インプラントの世界市場 - 2025年～2033年

Global Medical Implants Market - 2025-2033

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
医療用インプラントの世界市場 - 2025年～2033年
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の医療用インプラント市場は、2024年に1,175億米ドルに達し、2033年には2,249億米ドルに達すると予測され、予測期間2025年～2033年のCAGRは7.5%で成長するとされています。

医療用インプラントは、外科的または非外科的に体内または体表面に埋入され、生体構造の置換、支持、強化、機能回復、審美性の向上を図る装置です。インプラントは、病状や希望する結果に応じて、永久的または取り外し可能なように設計されています。インプラントは通常、整形外科、心臓病学、神経学、歯科、美容外科など、様々な医療分野で使用されています。医療用インプラントの開発と利用には、安全性、機能性、患者の幸福を確保するために、材料科学、生体医工学、外科手術の実践など、学際的な専門知識が必要です。

医療用インプラントの世界の需要は、医療技術の進歩や慢性疾患の蔓延の増加に牽引され、急速に伸びています。例えば、米国医師会によると、米国人の10人に1人（約10％）が生涯のどこかで医療機器を体内に埋め込むことになるといいます。この需要を促進する主な要因としては、高齢者人口の増加、心血管疾患や関節炎などの疾患の流行、生体材料や低侵襲手術技術の進歩などが挙げられます。

市場力学：

促進要因と抑制要因

医療用インプラントにおける技術進歩の高まり

医療用インプラントにおける技術進歩の高まりは、医療用インプラント市場の成長を大きく後押ししており、予測期間中も市場を牽引すると予測されます。バイオポリマーや生分解性インプラントなどの生体材料は、その生体適合性、強度、耐久性により、ますます使用されるようになってきています。これらのインプラントは免疫反応のリスクを低減し、患者のインプラント受容性を向上させる。

例えば、2024年8月、ストライカーはインドで、修復不可能な巨大腱板断裂（MIRCT）の関節鏡治療用として、世界初の生分解性肩峰下バルーンインプラント「InSpace」を発売しました。MIRCTは肩関節機能障害の最も一般的な原因の一つです。InSpaceは、外科医に肩関節治療の新たな選択肢を提供し、患者のニーズに応えることを可能にします。InSpaceバルーンインプラントは、縫合や固定器具を必要とせずに肩峰下腔を回復するように設計されており、肩の動きと機能を改善することが実証されています。

3Dプリンティングは、患者固有の解剖学的ニーズに基づいたカスタマイズを可能にすることで、インプラントの製造に革命をもたらしました。この技術は、よりフィットし、より効果的な、精密で複雑なオーダーメイドのインプラントを作成することで、手術結果を改善します。3Dプリントインプラント市場は、費用対効果が高く、カスタマイズ可能なソリューションを短いリードタイムで製造できることから、成長が見込まれています。

例えば、2024年4月、3Dシステムズは、3Dプリントされた患者専用の頭蓋インプラントソリューションであるVSP PEEK Cranial Implantの食品医薬品局（FDA）510（k）認可を発表しました。VSP PEEK Cranial Implantには、セグメンテーションと3Dモデリング・ソフトウェア、3D Systems EXT 220 MED 3Dプリンター、Evonik VESTAKEEP i4 3DF PEEK（ポリエーテルエーテルケトン）、および事前に定義された製造工程から成る、FDA認可済みの完全なワークフローが含まれています。付加製造ソリューションを活用することで、この技術は、従来の機械加工で製造された同様のインプラントよりも最大85％少ない材料で患者固有の頭蓋インプラントを製造することができ、インプラント用PEEKのような高価な原材料の大幅なコスト削減につながります。

インプラントの高コスト

医療用インプラントのコストが高いことは、特に低所得地域や経済的に恵まれない患者のアクセスを制限し、市場の成長を著しく阻害しています。整形外科の人工関節のような高級インプラントには、チタン合金やセラミックのような高価な材料が使われることが多く、製造や購入にコストがかかります。そのため、インプラントの初期価格が高くなり、多くの患者やヘルスケアシステムにとって手の届かないものになっています。

例えば、Journal of Orthopaedic Business誌によると、標準的な膝関節インプラントの平均費用は5,336ドル＋-1,671ドルで、一次人工膝関節全置換術（TKA）の平均総費用は23,907ドル＋-9,514ドルでした。標準的な人工膝関節の費用は、一次人工膝関節全置換術の総費用の22.3％を占めています。

インプラントの高額な費用は、ヘルスケアシステムに経済的負担を強いています。米国のような国々では、ヘルスケア支出のかなりの部分が、インプラントを含む高コストの手技に向けられています。そのため、患者の保険料や自己負担額が高くなり、市場全体の成長に影響を与える可能性があります。

例えば、歯科インプラントは1本の歯に3000ドルから7000ドルかかります。この価格には、外科手術で顎の骨に埋め込むチタン製のポストであるインプラント本体と、アバットメント、クラウンが含まれます。クラウンは、通常、ポーセレンまたはジルコニアで作られ、天然歯の外観と機能を模倣します。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 製品タイプ別
  • 材料別
  • 用途別
  • エンドユーザー別
  • 地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 医療用インプラントにおける技術進歩の高まり
      • 美容整形手術の需要増加
    • 抑制要因
      • インプラントの高額な費用
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 医療用インプラント市場、製品タイプ別

  • 整形外科用インプラント
  • 心臓血管インプラント
  • 神経刺激装置
  • 歯科インプラント
  • 人工内耳
  • 眼科インプラント
  • その他

第6章 医療用インプラント市場、材料別

  • セラミックインプラント
  • ポリマーインプラント
  • 金属インプラント
  • 複合インプラント
  • その他

第7章 医療用インプラント市場、用途別

  • 整形外科
  • 心臓病学
  • 神経学
  • 眼科
  • 歯科
  • その他

第8章 医療用インプラント市場、エンドユーザー別

  • 病院
  • 専門クリニック
  • 外来手術センター
  • その他

第9章 医療用インプラント市場、地域別、市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第11章 企業プロファイル

  • Stryker Corporation
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Dentsply Sirona
  • ZimVie Inc.
  • Johnson & Johnson
  • Zimmer Biomet Holdings, Inc.
  • Smith+Nephew
  • Boston Scientific Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Cochlear Ltd.
  • Wright Medical Group N.V.

第12章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第13章 付録

目次
Product Code: MD1907

The global medical implants market reached US$ 117.5 billion in 2024 and is expected to reach US$ 224.9 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.

A medical implant is a device that is surgically or non-surgically placed inside or on the surface of the body to replace, support, or enhance a biological structure, restore function, or improve aesthetics. Implants are designed to either be permanent or removable, depending on the medical condition or the desired outcome. They are typically used in various medical fields, including orthopedics, cardiology, neurology, dentistry, and cosmetic surgery. Medical implant development and utilization involve interdisciplinary expertise in materials science, biomedical engineering, and surgical practices to ensure safety, functionality, and patient well-being.

The global demand for medical implants is growing rapidly, driven by advancements in medical technology and the rising prevalence of chronic diseases. For instance, according to the American Medical Association, one in 10 Americans (about 10% of Americans) will have a medical device implanted into their bodies at some point in their lifetimes. Key factors driving this demand include the increasing geriatric population, the prevalence of conditions like cardiovascular diseases and arthritis, and advancements in biomaterials and minimally invasive surgical techniques.

Market Dynamics: Drivers & Restraints

Rising technological advancements in medical implants

The rising technological advancements in medical implants are significantly driving the growth of the medical implants market and are expected to drive the market over the forecast period. Biomaterials such as biopolymers and biodegradable implants are being increasingly used due to their biocompatibility, strength and durability. These implants reduce the risk of immune responses and improve patient acceptance of implants.

For instance, in August 2024, Stryker launched a first-of-its-kind biodegradable subacromial balloon implant, InSpace, the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs), in India. MIRCTs are one of the most common causes of shoulder dysfunction. InSpace provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients. The InSpace balloon implant is designed to restore the subacromial space without requiring sutures or fixation devices and has been demonstrated to improve shoulder motion and function.

3D printing has revolutionized the production of implants by allowing customization based on patient-specific anatomical needs. This technology improves surgical outcomes by creating precise, complex and tailored implants that fit better and are more effective. The market for 3D-printed implants is expected to grow due to its ability to produce cost-effective, customizable solutions with shorter lead times.

For instance, in April 2024, 3D Systems announced the Food and Drug Administration (FDA) 510(k) clearance for its 3D-printed, patient-specific cranial implant solution, VSP PEEK Cranial Implant. VSP PEEK Cranial Implant includes a complete FDA-cleared workflow comprising segmentation and 3D modeling software, the 3D Systems EXT 220 MED 3D printer, Evonik VESTAKEEP i4 3DF PEEK (polyetheretherketone), and a pre-defined production process. By utilizing additive manufacturing solutions, this technology can produce patient-specific cranial implants with up to 85% less material than similar implants produced by traditional machining, which can lead to significant cost savings for an expensive raw material like implantable PEEK.

The high cost of the implants

The high cost of medical implants significantly hampers the growth of the market by limiting access, especially in low-income regions and among economically disadvantaged patients. High-end implants, such as orthopedic joint replacements, often use expensive materials like titanium alloys and ceramics, which are costly to manufacture and purchase. This increases the initial price of the implant, making it unaffordable for many patients and healthcare systems.

For instance, according to the Journal of Orthopaedic Business, the mean cost of the standard knee implant was $5,336 +- $1,671 and the mean total cost of primary total knee arthroplasty (TKA) was $23,907 +- $9,514. The cost of the standard knee implant contributes to 22.3% of the total cost of a primary total knee arthroplasty.

The high cost of implants creates an economic burden on healthcare systems. In countries like the U.S., a significant portion of healthcare spending is directed toward high-cost procedures involving implants. This can lead to higher insurance premiums and out-of-pocket expenses for patients, affecting overall market growth.

For instance, dental implants cost between $3000 and $7000 for one tooth. This price includes the implant itself, which is the titanium post that's surgically placed into the jawbone, as well as the abutment and the crown. The crown, usually made of porcelain or zirconia, mimics the natural tooth's look and function.

Segment Analysis

The global medical implants market is segmented based on product type, material, application, end-user and region.

Product Type:

The orthopedic implants segment is expected to dominate the medical implants market share

The global aging population is a significant driver for orthopedic implants. As the population ages, there is a rise in conditions like arthritis, osteoporosis, and fractures due to falls, leading to higher demand for implants such as joint replacements and spinal devices. For instance, according to the Bone and Joint Burden Organization, roughly one in four (24.5%) musculoskeletal diseases occurs in persons aged 65 years and older. Almost 40% of musculoskeletal diseases occur among persons aged 45 to 64 years, increasing demand for orthopedic implants.

Advances in orthopedic implants have enabled the production of customized implants that are more precise and better suited to individual patient anatomies. This has improved outcomes and reduced recovery times for procedures such as hip and knee replacements. For instance, in April 2024, Onkos Surgical cleared that the U.S. Food & Drug Administration (FDA) granted a De Novo approval for its novel antibacterial-coated implants. Bacterial contamination of a permanent implant may have devastating effects, particularly in orthopedic oncology and revision arthroplasty applications where the patient population is highly vulnerable.

Major players in the orthopedic implants market, such as Johnson & Johnson, Stryker and Zimmer Biomet, are driving growth through continuous innovation and acquisition of smaller companies with advanced technologies. Their extensive product portfolios covering joint replacement systems, spine implants, and trauma devices are pivotal in maintaining dominance in the market.

For instance, in December 2024, Zimmer Biomet Holdings, Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona SoluTion Porous Plasma Spray (PPS) Femur, a total knee implant component offering an alternative for patients with sensitivities to bone cement and/or metal. The Persona SoluTion PPS Femur features a porous coating for cementless fixation and leverages a proprietary surface treatment designed to enhance wear performance.

Geographical Analysis

North America is expected to hold a significant position in the medical implants market share

North America, particularly the United States, boasts a highly developed healthcare system with access to advanced medical technologies and skilled healthcare providers. The presence of well-equipped hospitals and specialized treatment centers facilitates the adoption of new medical implants. For instance, according to the American Academy of Implant Dentistry, in the US, over a million are treated with dental implants each year (corresponding to 2.5 million implants).

North America is a hub for medical research and innovation. The collaboration between academic institutions, healthcare providers, and industry leaders accelerates the development of advanced medical implants. Companies like Medtronic, Johnson & Johnson, Boston Scientific and other emerging players are headquartered in the United States, where they conduct extensive R&D to develop cutting-edge medical devices. This environment supports the launch of new products and technologies, thereby maintaining North America's market dominance.

For instance, in December 2024, Mentor Worldwide LLC, part of Johnson & Johnson MedTech, announced the U.S. Food and Drug Administration (FDA) approved MENTOR MemoryGel Enhance Breast Implants for primary and revision reconstruction breast surgery in post-mastectomy women. This first-of-its-kind silicone gel-filled implant line features an expanded range of base widths, projections and volumes in an entirely new range of sizes extending from 930 cc to 1445 cc, the largest on the market. Mentor plans to commercially launch MemoryGel Enhance Breast Implants in the U.S. beginning in mid-2025.

Additionally, in October 2024, X-Bolt Orthopedics, an emerging innovator of orthopedic trauma devices, announced the successful completion of the first U.S. implant using its Pro-X1 Trochanteric Nailing System in Florida. This milestone marks the official commercial launch of the company's flagship product and signifies a major step forward in applying X-Bolt's technology for hip fracture treatment across the U.S.

Asia-Pacific is growing at the fastest pace in the medical implants market

The adoption of advanced technologies such as 3D printing, minimally invasive surgical techniques, and smart implants is growing in the APAC region. These technologies allow for customized implants, better surgical outcomes and quicker recovery times, which are especially attractive in densely populated regions with a high demand for cost-effective treatments.

For instance, in August 2024, Stryker, a global leader in medical technologies, launched InSpace, the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs), in India. MIRCTs are one of the most common causes of shoulder dysfunction. InSpace provides a new option for surgeons in their shoulder continuum of care that allows them to better meet the needs of their patients.

Additionally, in September 2024, GC Aesthetics, a leading medical technology company committed to advancing women's health through innovative aesthetic and reconstructive breast solutions, launched the YOUTHLY brand in China, featuring its latest breast implant innovations: PERLE, Luna XT, and the latest version of The Round Collection, 100% filled.

The presence of global medical device manufacturers and increasing foreign direct investment in the healthcare sector are crucial factors. Companies like Zimmer Biomet (ZimVie), Medtronic, Johnson & Johnson, and Boston Scientific are expanding their footprint in APAC, either through local manufacturing facilities or distribution partnerships. These investments are boosting product availability and enabling quicker adoption of new medical technologies.

For instance, in February 2024, ZimVie Inc., a global life sciences leader in the dental and spine markets, launched TSX Implant in Japan. As ZimVie's largest dental implant market in APAC and the fifth largest market globally, Japan is of great strategic importance to ZimVie. The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space.

Competitive Landscape

The major global players in the medical implants market include Stryker Corporation, Dentsply Sirona, ZimVie Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., Smith+Nephew, Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., Cochlear Ltd., Wright Medical Group N.V. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical implants market report delivers a detailed analysis with 70 key tables, more than 72 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in Medical Implants
      • 3.1.1.2. Rising Demand for Cosmetic Procedures
    • 3.1.2. Restraints
      • 3.1.2.1. The High Cost of The Implants
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Medical Implants Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Orthopedic Implants*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Cardiovascular Implants
  • 5.4. Neurostimulators
  • 5.5. Dental Implants
  • 5.6. Cochlear Implants
  • 5.7. Ophthalmic Implants
  • 5.8. Others

6. Medical Implants Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Ceramic Implants*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Polymeric Implants
  • 6.4. Metallic Implants
  • 6.5. Composite Implants
  • 6.6. Others

7. Medical Implants Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Orthopedics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Cardiology
  • 7.4. Neurology
  • 7.5. Ophthalmology
  • 7.6. Dentistry
  • 7.7. Others

8. Medical Implants Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Ambulatory Surgical Centers
  • 8.5. Others

9. Medical Implants Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Stryker Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Dentsply Sirona
  • 11.3. ZimVie Inc.
  • 11.4. Johnson & Johnson
  • 11.5. Zimmer Biomet Holdings, Inc.
  • 11.6. Smith+Nephew
  • 11.7. Boston Scientific Corporation
  • 11.8. Meril Life Sciences Pvt. Ltd.
  • 11.9. Cochlear Ltd.
  • 11.10. Wright Medical Group N.V.

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us